Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-09-26 4:54 pm Purchase |
2022-09-14 | 13G | POINT Biopharma Global Inc. PNT |
BIOTECHNOLOGY VALUE FUND L P | 5,590,048 5.400% |
2,669,522![]() (+91.41%) |
Filing History |
2022-08-26 5:11 pm Purchase |
2022-08-16 | 13G | Vigil Neuroscience, Inc. VIGL |
BIOTECHNOLOGY VALUE FUND L P | 2,739,727 7.500% |
2,739,727![]() (New Position) |
Filing History |
2022-08-23 4:45 pm Purchase |
2022-08-22 | 13D | Kymera Therapeutics, Inc. KYMR |
BIOTECHNOLOGY VALUE FUND L P | 4,692,604 8.600% |
553,846![]() (+13.38%) |
Filing History |
2022-08-11 4:48 pm Purchase |
2022-08-09 | 13D | CTI BioPharma Corp. CTIC |
BIOTECHNOLOGY VALUE FUND L P | 28,463,021 19.990% |
11,339,998![]() (+66.23%) |
Filing History |
2022-07-29 4:37 pm Purchase |
2022-07-27 | 13G | CytomX Therapeutics, Inc. CTMX |
BIOTECHNOLOGY VALUE FUND L P | 6,595,801 10.100% |
792,101![]() (+13.65%) |
Filing History |
2022-07-19 5:13 pm Sale |
2022-07-15 | 13G | ContraFect Corporation CFRX |
BIOTECHNOLOGY VALUE FUND L P | 23,091 4.500% |
-26,563![]() (-53.50%) |
Filing History |
2022-07-12 4:40 pm Purchase |
2022-07-08 | 13G | ESSA Pharma Inc. EPIX |
BIOTECHNOLOGY VALUE FUND L P | 8,748,629 19.900% |
4,183,387![]() (+91.64%) |
Filing History |
2022-07-11 5:03 pm Purchase |
2022-06-29 | 13G | 89bio, Inc. ETNB |
BIOTECHNOLOGY VALUE FUND L P | 3,898,000 9.990% |
3,898,000![]() (New Position) |
Filing History |
2022-06-21 4:53 pm Purchase |
2022-06-16 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
BIOTECHNOLOGY VALUE FUND L P | 4,007,413 12.400% |
2,001,551![]() (+99.79%) |
Filing History |
2022-06-16 5:24 pm Purchase |
2022-06-06 | 13G | Centessa Pharmaceuticals plc CNTA |
BIOTECHNOLOGY VALUE FUND L P | 6,894,345 7.300% |
6,894,345![]() (New Position) |
Filing History |
2022-06-06 5:25 pm Purchase |
2022-06-02 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 8,141,988 19.400% |
3,283,227![]() (+67.57%) |
Filing History |
2022-06-01 5:00 pm Purchase |
2022-05-27 | 13D | Kymera Therapeutics, Inc. KYMR |
BIOTECHNOLOGY VALUE FUND L P | 4,138,758 8.000% |
552,100![]() (+15.39%) |
Filing History |
2022-05-26 5:09 pm Purchase |
2022-05-16 | 13G | Annexon, Inc. ANNX |
BIOTECHNOLOGY VALUE FUND L P | 3,343,194 8.700% |
3,343,194![]() (New Position) |
Filing History |
2022-05-02 5:02 pm Purchase |
2022-04-22 | 13G | iTeos Therapeutics, Inc. ITOS |
BIOTECHNOLOGY VALUE FUND L P | 1,929,201 5.400% |
1,929,201![]() (New Position) |
Filing History |
2022-05-02 4:59 pm Purchase |
2022-04-22 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 1,964,859 5.100% |
1,964,300![]() (+351395.35%) |
Filing History |
2022-04-18 4:49 pm Purchase |
2022-04-05 | 13D | MoonLake Immunotherapeutics MLTX |
BIOTECHNOLOGY VALUE FUND L P | 21,751,284 58.900% |
21,751,284![]() (New Position) |
Filing History |
2022-04-04 4:38 pm Purchase |
2022-03-25 | 13G | AN2 Therapeutics, Inc. ANTX |
BIOTECHNOLOGY VALUE FUND L P | 1,616,665 8.600% |
1,616,665![]() (New Position) |
Filing History |
2022-03-24 4:22 pm Purchase |
2022-03-14 | 13G | Tyra Biosciences, Inc. TYRA |
BIOTECHNOLOGY VALUE FUND L P | 2,472,327 5.900% |
2,472,327![]() (New Position) |
Filing History |
2022-03-18 7:18 pm Sale |
2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
BIOTECHNOLOGY VALUE FUND L P | 4,305,540 8.200% |
-851,946![]() (-16.52%) |
Filing History |
2022-03-14 4:48 pm Purchase |
2022-03-03 | 13G | Arcus Biosciences, Inc. RCUS |
BIOTECHNOLOGY VALUE FUND L P | 3,960,948 5.600% |
1,208,726![]() (+43.92%) |
Filing History |